A Study in Participants With End-Stage Renal Disease

NCT01200290 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure, Chronic

Interventions

DRUG: LY2127399

Sponsor

Eli Lilly and Company